Medical cannabis has become a subject of increasing global research, with clinical studies now exploring its therapeutic potential across a wide range of medical conditions. Although evidence continues to evolve, several areas show consistent scientific interest and growing
clin cal support.
1:Pain Management
Chronic pain—particularly neuropathic pain—remains one of the most studied indications.Cannabinoids may modulate pain perception by interacting with CB1 and CB2 receptors of the endocannabinoid system. Some clinical trials suggest that cannabinoids may reduce reliance on certain pain medications in appropriate patient populations, although individualized dosing and medical oversight remain essential.
2:Sleep Disorders
Certain cannabis preparations, particularly those containing THC, have shown potential in improving sleep latency and quality. Emerging evidence also suggests that balanced THC:CBD formulations may be useful for insomnia related to chronic pain, anxiety, or neurodegenerative conditions.
3:Anxiety and PTSD
CBD is increasingly investigated for its anxiolytic properties. Preclinical and clinical studies
indicate that it may influence serotonin pathways and reduce hyperarousal. PTSD-focused
trials have examined both THC and CBD as potential modulators of nightmares and sleep
disturbances, though therapeutic outcomes vary by individual.
4:Epilepsy and Neurological Conditions
CBD has demonstrated efficacy in certain rare, treatment-resistant epilepsies, such as Dravet and Lennox-Gastaut syndromes. This led to the approval of CBD-based medications in several countries. Research is ongoing in areas such as multiple sclerosis (muscle spasticity), Parkinson’s disease, and neuroinflammation.
5:Oncology and Palliative Care
Cannabis is being studied for symptom management in cancer patients—including appetite stimulation, nausea reduction, and improved quality of life. Research into potential anti- proliferative effects is ongoing but remains preliminary.